Healthpeak Properties, Inc. (DOC)

2 members of Congress have disclosed trading DOC — 1 purchase and 3 sales worth an estimated $32,000. Most recent disclosure: May 15, 2025.

Healthpeak Properties, Inc. is a Standard & Poor's 500 company that owns, operates, and develops high-quality real estate focused on healthcare discovery and delivery in the United States. Our company was originally founded in 1985. We are organized as an umbrella partnership REIT. We hold substantially all our assets and conduct our operations through our operating subsidiary, Healthpeak OP, a consolidated subsidiary of which we are the managing member. We are a Maryland corporation and qualify as a self-administered REIT. We are headquartered in Denver, Colorado, with additional corporate offices in California, Tennessee, Wisconsin, and Massachusetts and property management offices in several locations throughout the U.S. We have a diversified portfolio of high-quality healthcare properties across three core asset classes of outpatient medical, lab, and continuing care retirement community real estate. Under the outpatient medical and lab segments, we own, operate, and develop outpatient medical buildings, hospitals, and lab buildings. Under the CCRC segment, our properties are operated through RIDEA structures. We have other non-reportable segments that are comprised primarily of: (i) an interest in an unconsolidated joint venture that owns 19 senior housing assets, (ii) loans receivable, and (iii) a preferred equity investment. These non-reportable segments have been presented on a combined basis herein. At September 30, 2025, our portfolio of investments, including properties in certain of our unconsolidated joint ventures, consisted of interests in 703 properties: (i) Outpatient medical – 530 properties; (ii) Lab – 139 properties; (iii) CCRC – 15 properties; and (iv) Other non-reportable – 19 properties. Healthpeak Properties, Inc. was incorporated in 1985 in Maryland, USA.

Company website ↗

• P/E ratio (67.3) — how many dollars you pay for each $1 of DOC's yearly profit. That's high, so the market expects strong growth (and you're paying up for it).
• ROE (2.80%) — how efficiently the company turns shareholders' money into profit. This is a middling level.
• Profit margin (7.73%) — of every $1 in sales, this is what's left as profit after all costs.
• Dividend yield (5.66%) — the cash payout you'd earn per year as a % of the share price, on top of any price gains.